Inflammation, cerebral vasospasm, and brain injury in subarachnoid hemorrhage-a shifting paradigm and a new beginning

Sherry Hsiang Yi Chou

doi:10.1097/CCM.0000000000003373

Inflammation, cerebral vasospasm, and brain injury in subarachnoid hemorrhage-a shifting paradigm and a new beginning

Sherry Hsiang Yi Chou^*

^*Corresponding author for this work

Neurology

Research output: Contribution to journal › Editorial › peer-review

8 Scopus citations

Original language	English (US)
Pages (from-to)	1883-1885
Number of pages	3
Journal	Critical care medicine
Volume	46
Issue number	11
DOIs	https://doi.org/10.1097/CCM.0000000000003373
State	Published - 2018

Funding

*See also p. e1023. Key Words: biomarker; cerebral vasospasm; delayed cerebral ischemia; inflammation; subarachnoid hemorrhage Dr. Chou’s institution received funding from National Institute of Health (NIH)/National Institute of Neurological Disorders and Stroke K23 award and Edge Therapeutics (site principal investigator at University of Pittsburgh Medical Center for Newton 2 clinical trial); she received funding from Partners Healthcare (patent royalties), local grant support from University of Pittsburgh Physicians, the University of Pittsburgh School of Medicine Dean’s Faculty Advancement Award, and she served on the board of directors for Neurocritical Care Society (end date: October 2017); and she received support for article research from the NIH. Copyright © 2018 by the Society of Critical Care Medicine and Wolters Kluwer Health, Inc. All Rights Reserved.

Keywords

Biomarker
Cerebral vasospasm
Delayed cerebral ischemia
Inflammation
Subarachnoid hemorrhage

ASJC Scopus subject areas

Critical Care and Intensive Care Medicine

Access to Document

10.1097/CCM.0000000000003373

Cite this

@article{664ac5d0f4cf4668957554a93409876d,

title = "Inflammation, cerebral vasospasm, and brain injury in subarachnoid hemorrhage-a shifting paradigm and a new beginning",

keywords = "Biomarker, Cerebral vasospasm, Delayed cerebral ischemia, Inflammation, Subarachnoid hemorrhage",

author = "Chou, {Sherry Hsiang Yi}",

note = "Funding Information: *See also p. e1023. Key Words: biomarker; cerebral vasospasm; delayed cerebral ischemia; inflammation; subarachnoid hemorrhage Dr. Chou{\textquoteright}s institution received funding from National Institute of Health (NIH)/National Institute of Neurological Disorders and Stroke K23 award and Edge Therapeutics (site principal investigator at University of Pittsburgh Medical Center for Newton 2 clinical trial); she received funding from Partners Healthcare (patent royalties), local grant support from University of Pittsburgh Physicians, the University of Pittsburgh School of Medicine Dean{\textquoteright}s Faculty Advancement Award, and she served on the board of directors for Neurocritical Care Society (end date: October 2017); and she received support for article research from the NIH. Copyright {\textcopyright} 2018 by the Society of Critical Care Medicine and Wolters Kluwer Health, Inc. All Rights Reserved.",

year = "2018",

doi = "10.1097/CCM.0000000000003373",

language = "English (US)",

volume = "46",

pages = "1883--1885",

journal = "Critical care medicine",

issn = "0090-3493",

publisher = "Lippincott Williams and Wilkins",

number = "11",

}

TY - JOUR

T1 - Inflammation, cerebral vasospasm, and brain injury in subarachnoid hemorrhage-a shifting paradigm and a new beginning

AU - Chou, Sherry Hsiang Yi

N1 - Funding Information: *See also p. e1023. Key Words: biomarker; cerebral vasospasm; delayed cerebral ischemia; inflammation; subarachnoid hemorrhage Dr. Chou’s institution received funding from National Institute of Health (NIH)/National Institute of Neurological Disorders and Stroke K23 award and Edge Therapeutics (site principal investigator at University of Pittsburgh Medical Center for Newton 2 clinical trial); she received funding from Partners Healthcare (patent royalties), local grant support from University of Pittsburgh Physicians, the University of Pittsburgh School of Medicine Dean’s Faculty Advancement Award, and she served on the board of directors for Neurocritical Care Society (end date: October 2017); and she received support for article research from the NIH. Copyright © 2018 by the Society of Critical Care Medicine and Wolters Kluwer Health, Inc. All Rights Reserved.

PY - 2018

Y1 - 2018

KW - Biomarker

KW - Cerebral vasospasm

KW - Delayed cerebral ischemia

KW - Inflammation

KW - Subarachnoid hemorrhage

UR - http://www.scopus.com/inward/record.url?scp=85054893070&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85054893070&partnerID=8YFLogxK

U2 - 10.1097/CCM.0000000000003373

DO - 10.1097/CCM.0000000000003373

M3 - Editorial

C2 - 30312238

AN - SCOPUS:85054893070

SN - 0090-3493

VL - 46

SP - 1883

EP - 1885

JO - Critical care medicine

JF - Critical care medicine

IS - 11

ER -

Inflammation, cerebral vasospasm, and brain injury in subarachnoid hemorrhage-a shifting paradigm and a new beginning

Funding

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this